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Abstract. 
 
The cortical scaffolding proteins EBP50
(ERM-binding phosphoprotein-50) and E3KARP
(NHE3 kinase A regulatory protein) contain two PDZ
(PSD-95/DlgA/ZO-1–like) domains followed by a
COOH-terminal sequence that binds to active ERM
family members. Using afﬁnity chromatography, we
identiﬁed polypeptides from placental microvilli that
bind the PDZ domains of EBP50. Among these are 64-
and/or 65-kD differentially phosphorylated polypeptides
that bind preferentially to the ﬁrst PDZ domain of
EBP50, as well as to E3KARP, and that we call EPI64
(EBP50–PDZ interactor of 64 kD). The gene for human
EPI64 lies on chromosome 22 where nine exons specify
a protein of 508 residues that contains a Tre/Bub2/
Cdc16 (TBC)/rab GTPase-activating protein (GAP)
domain. EPI64 terminates in DTYL, which is necessary
for binding to the PDZ domains of EBP50, as a mutant
ending in DTYLA no longer interacts. EPI64 colocalizes
with EBP50 and ezrin in syncytiotrophoblast and cultured
cell microvilli, and this localization in cultured cells is
abolished by introduction of the DTYLA mutation. In
addition to EPI64, immobilized EBP50 PDZ domains
retain several polypeptides from placental microvilli,
including an isoform of nadrin, a rhoGAP domain–
containing protein implicated in regulating vesicular
transport.  Nadrin binds EBP50 directly, probably
through its COOH-terminal STAL sequence. Thus,
EBP50 appears to bind membrane proteins as well as fac-
tors potentially involved in regulating membrane trafﬁc.
Key words: ezrin • microﬁlaments • membrane trafﬁc
• NHE-RF • nadrin
 
Introduction
 
The plasma membrane and associated cortical cytoskele-
ton is the interface that eukaryotic cells have between the
extracellular matrix, adjacent cells, and their environment.
Consequently, the cell cortex is assembled into functional
domains. For example, polarized epithelial cells have dis-
tinct protein and lipid compositions in the apical and baso-
lateral domains that are separated by tight junctions (for
review see Keller and Simons, 1997). The cortical cytoskel-
eton performs many functions; it provides structural sup-
port for the plasma membrane, it participates in signaling
pathways, and it participates in both endocytosis and exo-
cytosis. Given its broad array of functions, it is not surpris-
ing that the cortical membrane organization is a complex
structure of interacting proteins. As a contribution to un-
derstanding the cell cortex, we have set out to characterize
the organization and function of the proteins that make up
the apical cortex of epithelial cells and to elucidate their
roles in regulating events at the plasma membrane.
A major component of the apical cortical cytoskele-
ton of epithelial cells is ezrin, an 81-kD polypeptide origi-
nally isolated from intestinal epithelial cell microvilli (Bret-
scher, 1983). Subsequent work on ezrin identified it as a
member of the ezrin/radixin/moesin (ERM)
 
1
 
 family of
membrane–cytoskeleton linking proteins (for reviews see
Mangeat et al., 1999; Bretscher et al., 2000). At the NH
 
2
 
terminus of the ERM proteins is a 
 
z
 
300-residue domain
referred to as a 4.1 ERM (FERM) domain, as it is the de-
fining feature of the 4.1-band superfamily of proteins
(Chishti et al., 1998). This domain associates with membrane
proteins, either directly through association with single-
pass membrane proteins such as CD44, CD43, I-CAM1, 2,
3, and syndecan-2 involved in adhesion (Tsukita et al.,
1994; Helander et al., 1996; Serrador et al., 1997, 1998;
Heiska et al., 1998; Legg and Isacke, 1998; Yonemura et
al., 1998), or indirectly through scaffolding proteins, such
as ERM-binding phosphoprotein 50 (EBP50) and NHE3 ki-
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nase A regulatory protein (E3KARP) (Reczek et al., 1997;
Reczek and Bretscher, 1998; Yun et al., 1998), to mem-
brane proteins (Hall et al., 1998a,b; Short et al., 1998;
Wang et al., 1998). In the 30 COOH-terminal residues of
the ERM proteins resides an F-actin binding site (Turunen
et al., 1994; Pestonjamasp et al., 1995; Berryman and
Bretscher, 2000), thus accounting for the view of ERM
proteins as microfilament–membrane linking proteins.
The linking function of ERM proteins is subject to con-
formational regulation. In the dormant state, ERM pro-
teins are unable to interact with at least some of their
ligands, including EBP50 and F-actin, because the binding
sites are masked (Gary and Bretscher, 1995; Reczek and
Bretscher, 1998). Masking is achieved by the association of
the 
 
z
 
100 COOH-terminal residues with the NH
 
2
 
-terminal
FERM domain (Gary and Bretscher, 1995; Magendantz et
al., 1995). Since the NH
 
2
 
-terminal domain of any ERM
member can asssociate with the COOH-terminal domain
of any member, these regions were called N-ERM associa-
tion domains (ERMADs) and C-ERMADs. Recent struc-
tural studies have provided a view of how the masking is
achieved: the N-ERMAD consists of a relatively compact
domain to which the C-ERMAD binds as a highly ex-
tended inhibitory peptide masking a remarkable amount
of the surfaces of both the N- and C-ERMAD (Pearson et
al., 2000). Activation is believed to result in dissociation of
the C-ERMAD from the N-ERMAD to reveal the inter-
face containing membrane and F-actin binding sites. Cur-
rently, activation is believed to be a two-step process
involving phosphatidylinositol 4,5-bisphosphate and phos-
phorylation of a conserved threonine 20 residues from
the COOH terminus (Nakamura et al., 1995, 1999; Niggli
et al., 1995; Hirao et al., 1996; Heiska et al., 1998; Matsui et
al., 1998; Pietromonaco et al., 1998; Huang et al., 1999;
Barret et al., 2000). In support of this mechanism, Hamada
et al. (2000) have suggested that binding of phosphati-
dylinositol 4,5-bisphosphate to the FERM domain results
in the movement of a peptide loop in the FERM domain
that is likely to reduce its affinity for the C-ERMAD,
and Pearson et al. (2000) have suggested that phosphory-
lation of the conserved threonine might destabilize the N-/
C-ERMAD interaction.
Based on our model for ezrin activation (Gary and
Bretscher, 1995), we previously sought to identify proteins
that might bind to the isolated, conformationally activated
NH
 
2
 
-terminal domain of ezrin and moesin. Although sev-
eral adhesion proteins had been shown to interact with
this domain, we reasoned that in epithelial cells, where the
ezrin-rich apical surface is not attached to the extracellular
matrix, other molecules might associate with ezrin. Since
ezrin is highly enriched in human placenta (Berryman et
al., 1995), we used this tissue as starting material for the
identification of proteins that bound immobilized NH
 
2
 
-
terminal domains of ezrin and moesin. This approach led
to the isolation and characterization of EBP50 (Reczek et
al., 1997; Reczek and Bretscher, 1998). EBP50 is the hu-
man homologue of rabbit Na
 
1
 
/H
 
1
 
 exchanger regulatory
factor described previously (for review see Weinman et
al., 2000). Human EBP50 is a 358-residue protein that
is significantly enriched in microvilli and contains two
related postsynaptic density (PSD)-95/DlgA/ZO-1–like
(PDZ) domains in its NH
 
2
 
-terminal half and an ERM
binding sequence in its COOH-terminal 30 residues. PDZ
domains frequently associate with specific COOH-termi-
nal sequences of transmembrane proteins (Songyang et
al., 1997) (for reviews see Saras and Heldin, 1996; Kornau
et al., 1997), and, indeed, the first PDZ domain of EBP50
has been shown to have specificity for the sequence D-(S/
T)-(R/Y)-L (Hall et al., 1998a; Wang et al., 1998) and to
bind to the cystic fibrosis transmembrane conductance
regulator (CFTR) (through -DTRL) (Yang and Tonks,
1991; Short et al., 1998), the 
 
b
 
2-adrenergic receptor
(
 
b
 
2AR) (through -DSLL) (Hall et al., 1998a,b; Cao et al.,
1999), and the PDGF receptor (through -DSFL) (Mauds-
ley et al., 2000). These interactions may be involved in re-
taining membrane proteins at the apical surface, as seems
to be the case for the CFTR (Short et al., 1998), or in regu-
lating the availability of EBP50 to bind to Na
 
1
 
/H
 
1
 
 ex-
changer isoform 3 (NHE3) (Hall et al., 1998b) or, as has
been shown for the 
 
b
 
2AR, in trafficking endocytosed re-
ceptor back to the plasma membrane (Cao et al., 1999).
EBP50 has also been shown to interact with the cytoplas-
mic proteins YAP65 (Mohler et al., 1999) and G protein–
coupled receptor kinase 6A (GRK6A) (Hall et al., 1999).
In addition to binding the ERM family members,
EBP50 was independently identified as a protein that
binds the NH
 
2
 
-terminal domain of merlin (Murthy et al.,
1998), the product of the neurofibromatosis II tumor sup-
pressor gene (Rouleau et al., 1993; Trofatter et al., 1993).
Another protein, E3KARP, has been identified that, like
EBP50, has closely related PDZ domains and a COOH-
terminal ERM binding domain. However, although
EBP50 binds both ERM proteins and merlin with high af-
finity, E3KARP binds much more readily to ERM pro-
teins than to merlin (Yun et al., 1997, 1998; Reczek and
Bretscher, 1998; Nguyen et al., 2001).
Since many of the proteins documented to bind the
PDZ domains of EBP50 are not expected to be enriched
in the apical aspect of all epithelial cells that contain
EBP50, we used affinity chromatography to identify pro-
teins from isolated placental microvilli that bind the PDZ
domains of EBP50. We have identified several binding
candidates. In particular, the placental form of nadrin
(Harada et al., 2000), a protein having a rhoGAP domain,
binds the PDZ domains of EBP50 as does a Tre/Bub2/
Cdc16 (TBC)/rabGAP domain–containing protein that we
refer to as EPI64. The focus of this report is on the isola-
tion and characterization of EPI64, the identification of
which adds further support for a role of EBP50 in regulat-
ing membrane traffic.
 
Materials and Methods
 
Human placenta was obtained from consenting patients at Tompkins
Community Hospital, Ithaca, NY. Adult female CD-1 mice were provided
by Dr. M. Salpeter and M. Strang (Cornell University). Restriction en-
zymes and other reagents for molecular biology were purchased from
GIBCO BRL and New England Biolabs, Inc.
 
Production and Purification of Recombinant Proteins
 
The design and production of the ezrin 1–296 (ezrin NH
 
2
 
-terminal do-
main), and glutathione 
 
S
 
-transferase (GST)–EBP50 constructs 1–358
(full-length EBP50), 1–97 (PDZ-1), 1–138 (PDZ-1
 
1
 
), 1–248 (PDZ-1
 
1
 
PDZ-2), and 241–358 (COOH-terminal half) have been described previ-
ously (Reczek et al., 1997; Reczek and Bretscher, 1998). GST–EBP50
138–248 (PDZ-2) was generated by subcloning the 0.35-kb NruI–EcoRI 
Reczek and Bretscher 
 
EPI64, a Microvillar PDZ Domain–binding Protein
 
193
 
fragment of GST–EBP50 1–248 into the SmaI–EcoRI sites of the pGEX-
2T vector (Amersham Pharmacia Biotech). To make the untagged EPI64
construct, the cDNA sequence encoding residues 1–508 was amplified
by PCR using primers that generated EcoRI and HindIII sites at the
ends. This product was subcloned into the pQE16 expression vector
(QIAGEN). The GST–EPI64 constructs were made similarly, using PCR
to amplify the cDNA sequence for residues 1–508 with primers generating
BamHI and EcoRI sites at the ends, except the 3
 
9
 
 primer used for the
DTYLA mutant encoded an additional alanine residue after the wild-type
sequence. These products were then subcloned into the pGEX-2T vector.
The Xpress epitope-tagged EPI64 constructs were derived from the GST–
EPI64 constructs by subcloning the appropriate BamHI–EcoRI EPI64
coding fragments into the EpiTag vector (Invitrogen). All recombinant
sequences were determined to be free of PCR errors by nucleotide se-
quence analysis. MBP-E3KARP was a gift from Dr. C. Yun (Johns Hop-
kins University, Baltimore, MD).
The expression of the ezrin NH
 
2
 
-terminal and GST–EBP50 constructs
has been described (Reczek et al., 1997; Reczek and Bretscher, 1998), and
the expression of GST–EBP50 138–248, and GST–EPI64 was carried out
similarly here. For the expression of untagged EPI64, the plasmid encod-
ing this construct was transformed into the 
 
Escherichia coli
 
 strain M15
[pRep4] (QIAGEN). Saturated overnight cultures were inoculated at 1:20
dilution in LB medium containing 100 
 
m
 
g/ml ampicillin and 25 
 
m
 
g/ml kana-
mycin and grown for 90 min at 37
 
8
 
C. Isopropyl 
 
b
 
-
 
D
 
-thiogalactopyranoside
was added to 2 mM, and cells were grown for an additional 180 min. Cells
were harvested by centrifugation at 8,000 
 
g
 
 for 15 min.
The purification of ezrin 1–296 has been described (Reczek et al.,
1997). The GST fusion proteins were purified according to the manufac-
turer’s protocol supplied with the vectors (Amersham Pharmacia Bio-
tech). To purify bacterially expressed untagged EPI64, induced cells from
50 ml of culture were resuspended in Tris-buffered saline (50 mM Tris,
150 mM NaCl, pH 7.4, at 4
 
8
 
C) containing 50 
 
m
 
g/ml phenylmethylsulfonyl
fluoride and 75 
 
m
 
g/ml benzamidine and lysed by sonication (Branson Ul-
trasonics Corp.). The resulting extract was clarified by centrifugation at
48,000 
 
g
 
 for 10 min, and the soluble supernatant was mixed with 50 
 
m
 
l of a
25% slurry of PDZ-1 
 
1
 
 PDZ-2 GST–EBP50–agarose beads for 45 min.
The beads were washed five times in 1 ml Tris-buffered saline, and bound
protein was eluted by boiling 2 min in SDS sample buffer (Laemmli, 1970)
or by the addition of Tris-buffered saline made up to 2 M NaCl.
 
Affinity Chromatography and Binding Assays
 
To prepare affinity resins, GST fusion proteins that had been purified ac-
cording to the manufacturer’s protocol were dialyzed into PBS and then
re-bound to glutathione–agarose at 
 
z
 
130 
 
m
 
M. Ezrin 1–296 beads were
made as described previously (Reczek et al., 1997).
Human placental microvilli were prepared as described by Berryman et
al. (1995). For extracts, fresh microvilli in saline, at 
 
z
 
10 mg/ml total pro-
tein concentration, were pelleted by centrifugation at 20,000 
 
g
 
 for 30 min
and then resuspended and lysed in the same starting volume of ice-cold
extraction buffer (50 mM Tris, 300 mM NaCl, 1% Triton X-100, 50 
 
m
 
g/ml
phenylmethylsulfonyl fluoride, 75 
 
m
 
g/ml benzamidine, pH 7.4, at 4
 
8
 
C).
The extract was clarified by centrifugation at 100,000 
 
g
 
 for 30 min at 4
 
8
 
C,
and the resulting supernatant (final concentration 
 
z
 
5 mg/ml) was used to
set up binding reactions.
Affinity binding assay reactions were carried out by mixing 50 
 
m
 
l of
25% slurry of protein-coupled beads with 1 ml of soluble microvillar ex-
tract at 4
 
8
 
C for 90 min. The beads were washed three times in extract
buffer, followed by two washes in extract buffer without Triton X-100.
Bound extract proteins were eluted from the beads by two sequential elu-
tions in three-bed volumes of extract buffer made up to 2 M NaCl and
lacking Triton X-100. Eluates from the same reaction were pooled and
then boiled in SDS sample buffer.
 
Phosphatase Assays
 
Phosphatase treatment of EPI64 isolated from human placental mi-
crovilli was performed according to methods described previously (Rec-
zek et al., 1997).
 
Antibodies
 
Polyclonal antibodies to EPI64 were elicited in rabbits and affinity puri-
fied as described (Bretscher, 1983) using purified recombinant GST–
EPI64 as antigen. Monoclonal antibodies to the Xpress epitope tag were
purchased from Invitrogen.
 
SDS-PAGE, Blot Overlays, and Immunoblots
 
SDS-PAGE was performed according to (Laemmli, 1970). For some exper-
iments gels were stained with Coomasssie brilliant blue R-250 or were silver
stained (Oakley et al., 1980). For blots, proteins were transferred from gels
to polyvinylidene fluoride membranes using a semidry electroblotter (Inte-
grated Biosystems). All blots were developed using an enhanced chemilu-
minescence detection system (Amersham Pharmacia Biotech).
Blot overlays and probe biotinylation were carried out according to
methods described previously (Gary and Bretscher, 1993). For control ex-
periments, the biotinyl probes were omitted or, in the case of the MBP–
E3KARP fusion protein, biotinyl MBP alone was used.
Immunoblots were blocked in 10% nonfat dry milk and then probed
with 0.1 
 
m
 
g/ml affinity-purified EPI64 antibodies in 1% milk, followed by
0.1 
 
m
 
g/ml peroxidase-conjugated goat anti–rabbit IgG in 1% milk. Pri-
mary antibodies were omitted for control blots.
Murine tissue samples were obtained from adult female CD-1 mice.
Total SDS-soluble tissue and cell lysates were prepared as described pre-
viously (Reczek et al., 1997). Tissue and cell lysate samples analyzed by
SDS-PAGE were normalized according to total protein concentration.
 
Sequence Analysis
 
Affinity chromatography from extracts of human placental microvilli was
used on a large scale to isolate sufficient amounts of the 120-, 65-, and 64-
kD candidates for peptide microsequencing. Eluates were resolved by pre-
parative SDS-PAGE, the resultant gels were stained briefly with Coo-
massie brilliant blue R-250, and regions containing the desired bands were
excised and then washed in 50% acetonitrile. These samples were sent to
Harvard Microchem, where sequence analysis was performed by microcap-
illary reverse-phase HPLC nanoelectrospray tandem mass spectrometry
(
 
m
 
LC/MS/MS) on a Finnigan LCQ quadrupole ion trap mass spectrometer.
The Institute for Genomic Research human cDNA database was
searched using the EPI64 peptide sequences. cDNA clones that matched
these query sequences were obtained from Genome Systems Inc. The in-
sert sizes were determined by restriction endonuclease digestion using en-
zymes appropriate for the cloning sites in each library parent vector. The
cDNA insert of a clone from a human prostate library was sequenced in
its entirety using sets of primers that yielded overlapping sequence infor-
mation. All nucleotide sequencing was done using an automated cycle se-
quencer (model 373A; Applied Biosystems).
Protein and DNA sequence alignments and editing were done using
the software programs MEGALIGN and EDITSEQ (DNASTAR Inc.),
respectively.
 
Immunofluorescence Microscopy and Cell Transfection
 
Cryosections of human placenta were prepared and stained as described
previously (Berryman et al., 1993). Affinity-purified EPI64 antibodies
were used at 
 
z
 
3 
 
m
 
g/ml.
JEG-3 cultured cells were grown on glass coverslips in MEM supple-
mented with 10% FCS. Cells were transfected using Genejammer trans-
fection reagent (Stratagene) according to the manufacturer’s protocol. 24–
48 h after transfection, cells were fixed and stained for microscopy as
described by Franck et al. (1993) using a 1:400 dilution of anti-Xpress
monoclonal antibody (Invitrogen). In cases where cells or tissues were
double labeled, 
 
z
 
3 
 
m
 
g/ml affinity-purified EPI64, EBP50, or ezrin anti-
bodies were also used. Actin was stained with a 1:200 dilution of rho-
damine phalloidin (Molecular Probes, Inc.).
Cells and tissue sections were viewed with an Axiovert 100-TV fluores-
cence microscope (Carl Zeiss Inc.), and images were acquired using Meta-
morph imaging software (Universal Imaging Corp.).
 
Results
 
Identification of EBP50 PDZ Domain–binding Proteins
 
Both ezrin and EBP50 are highly enriched in human pla-
cental microvilli, so we used these isolated structures as
starting material in an attempt to identify physiologically
relevant proteins that bind the PDZ domains of EBP50. A
series of GST fusion proteins containing the first, the sec-
ond, or both PDZ domains of EBP50 (Fig. 1 A) were ex-
pressed as soluble proteins in bacteria. After purification, 
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they were re-bound to glutathione–agarose beads at
equimolar concentrations. The beads were incubated with
total detergent soluble extracts of human placental mi-
crovilli and then washed extensively, and bound proteins
were eluted in high salt buffer and resolved by SDS-
PAGE (Fig. 1 B). Beads with immobilized GST alone, or
the fusion proteins incubated with just buffer, served as
controls. In analyzing these results, it is necessary to iden-
tify those bands that are derived from the fusions proteins
(lanes 1–5) to determine which polypeptides originate
from the placental microvillar extract (lanes 6–10). Such
an analysis reveals that a distinct group of polypeptides at
 
z
 
120, 
 
z
 
65, and 
 
z
 
64 kD bound specifically to all fusion
proteins containing PDZ-1 (Fig. 1 B, lanes 7–10). How-
ever, these proteins clearly bound better to a construct of
PDZ-1 with additional COOH-terminal sequences (P1
 
1
 
),
rather than to the minimal PDZ-1 domain (P1), and bound
to a lesser extent to just PDZ-2 (P2). No binding was seen
to the control GST beads (lane 6). In addition to the 120-,
65-, and 64-kD bands, additional specific polypeptides
were also recovered in lower abundance on the various
PDZ domain beads, and these are discussed below.
Proteins retained on the GST–PDZ domain fusion pro-
tein beads may bind directly or indirectly. To identify
those that bound directly and as a further test of specific-
ity, biotin-labeled purified recombinant EBP50 was used
as a soluble probe in a blot overlay assay on duplicates of
the samples shown in Fig. 1 B (Fig. 1 C). A strong signal
was seen for the candidates at 64 and 65 kD (Fig. 1 C,
lanes 7–10), and a specific signal, although weaker on a
relative scale, was seen for the 120-kD candidate (Fig. 1 C,
lanes 8 and 10; and on longer exposure, lanes 7 and 9; data
not shown). The EBP50 probe also recognized these can-
didates in the starting total microvillar extracts (data not
shown). These results indicate that the interaction be-
tween the PDZ domains of EBP50 and the 120-, 65-, and
64-kD polypeptides is direct.
 
The 64/65-kD Polypeptides Contain a TBC/rabGAP 
Domain, and the 120-kD Polypeptide Is an Isoform of 
Nadrin, a rhoGAP Domain–containing Protein
 
To determine the identity of the proteins retained on the
P1
 
1
 
 beads, a larger scale purification was performed, and
the 64-, 65-, and 120-kD PDZ-binding polypeptides were
subjected to mass spectrometry-based sequence analysis.
A correlative search of the GenBank/EMBL/DDBJ and
EST databases with the masses of peptides derived from
the 64- and 65-kD candidates identified the same set of hu-
man ESTs coding for a novel human protein, indicating
that their difference in migration was likely due to some
form of posttranslational modification. Therefore, to ex-
amine the heterogeneity of the 64/65 kD doublet, an en-
Figure 1.  Identification of
EBP50 PDZ domain–bind-
ing candidates. (A) Summary
of GST–EBP50 fusion pro-
teins used for affinity chro-
matography. The cDNA se-
quences encoding human
EBP50 residues 1–358 (FL),
residues 1–97 (P1), residues
1–138 (P11), residues 138–
248 (P2), residues 1–248 (P1 1
P2), and residues 241–358
(C) were expressed as solu-
ble recombinant proteins
fused to GST. These pro-
teins were purified, immobi-
lized on glutathione–agarose
beads, and then used for af-
finity chromatography. (B)
Affinity chromatography.
Buffer or total detergent sol-
uble extracts of placental mi-
crovilli were mixed with
GST–agarose beads or GST–
EBP50–agarose beads con-
taining the first PDZ domain
(P1 or P11), the second
PDZ domain (P2), or both in
tandem (P1 1 P2). The
beads were then washed ex-
tensively in buffer at 0.3 M NaCl, and bound proteins were eluted and resolved on a 6–20% silver-stained gradient SDS gel. (C) One-
fourth the amount of the samples shown in B were resolved by SDS-PAGE, transferred to PVDF, and then probed with biotinylated
EBP50. Arrowheads and brackets indicate specific 120-kD and 64/65-kD binding candidates, respectively. The mobilities of molecular
mass standards in kD are indicated at left. DF, dye front. (D) The heterogeneity of the 64/65-kD candidate is due to phosphorylation. A
PDZ domain affinity bead eluate from B that was enriched in the 64/65-kD binding candidate was incubated in the presence (1AP) or
absence (2AP) of calf intestinal alkaline phosphatase and then resolved by SDS-PAGE on a 10% gel, transferred to PVDF, and over-
laid with biotinyl EBP50 probe as in C. 
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riched sample from placental microvilli was treated with
calf intestinal alkaline phosphatase. As shown in Fig. 1 D,
this resulted in the collapse of the 65-kD band into the 64-
kD species. Since immunoblots with antiphosphotyrosine
antibodies did not detect either of these species (data not
shown), the resulting modification is presumably due to ei-
ther serine and/or threonine phosphorylation. We refer to
these two polypeptides as EPI64.
The EST cDNA clones encoding peptides present in
EPI64 were obtained and sequenced. One of these, from a
human prostate library, contained an 
 
z
 
1.97-kb insert with
an open reading frame possessing all of the EPI64 derived
peptides (Fig. 2 A). In addition, it also contained a portion
of the 5
 
9
 
 untranslated region as well as the full 3
 
9
 
 untrans-
lated region, and a poly A tail. The reading frame encodes
a 508–amino acid protein with no predicted transmem-
brane domains and a calculated molecular mass of 57.1
kD. Interestingly, the deduced protein sequence of EPI64
ends in the amino acids DTYL, a motif that matches the
optimal peptide binding consensus sequence, D-(S/T)-(R/
Y)-L, determined for the first PDZ domain of EBP50
(Hall et al., 1998a,b; Wang et al., 1998). Thus, EPI64 ap-
pears to be a novel cytoplasmic protein that probably asso-
ciates with the PDZ domains of EBP50 via a typical PDZ
to COOH-terminal interaction.
Database searches revealed that the human EPI64 gene
resides at chromosome locus 22q12.1-qter. A comparison
of the cDNA and genomic sequences revealed that the
EPI64 gene consists of eight introns and nine exons, with
the first intron being exceptionally large, and spanning
over 22 kb (Fig. 2 B). Database searches also identified a
200–amino acid region in EPI64, between residues G111
and L311 (Fig. 2 A), that shows significant sequence iden-
tity to a broad range of proteins from diverse species. This
domain is generally referred to as the TBC/rabGAP do-
main (Richardson and Zon, 1995; Neuwald, 1997; Albert et
al., 1999), and it is conserved from humans to plants. Fig. 3
A shows an alignment of the EPI64 TBC/rabGAP domain
with those in proteins from a selection of various species.
A key feature of a rabGAP domain is a well-conserved
arginine, located at residue 160 in the EPI64 sequence, that
has been shown to be critical for the rab GTPase activity of
the yeast proteins Gyp1p and Gyp7p (Albert et al., 1999).
Thus, EPI64 has a TBC/rabGAP domain.
Two proteins in particular were found to be quite
closely related to EPI64: a 533–amino acid unnamed hu-
man protein (sequence data available from GenBank/
EMBL/DDBJ under accession number BAB14454), and a
532–amino acid uncharacterized ascidian protein, HrPET-1
(sequence data available from GenBank/EMBL/DDBJ
under accession number BAA81906); an alignment of
these proteins with EPI64 is shown in Fig. 3 B. The
BAB14454 protein and HrPET-1 show 
 
z
 
67 and 
 
z
 
40%
overall sequence identity to EPI64, and 
 
z
 
82 and 
 
z
 
54%
identity with the TBC/rabGAP domain of EPI64, respec-
tively. Information submitted to GenBank/EMBL/DDBJ
for HrPET-1 suggests that it may play some role in a local-
ization pathway of maternal RNAs at the posterior–vege-
tal cytoplasm in early ascidian embryos. No additional in-
formation is available for the BAB14454 database entry.
Although these two proteins do not share identical
COOH-terminal sequences with EPI64, they do show con-
servation of sequence with EPI64 outside the TBC/rab-
GAP domain. These two proteins also demonstrate 
 
z
 
40%
sequence identity to each other, and as such, it is difficult
to discern whether HrPET-1 is the homologue of EPI64 or
of the human BAB14454 protein. Based on total residue
length, it is perhaps more likely that BAB14454 and Hr-
PET-1 are homologues. Regardless, both BAB14454 and
HrPET-1 are close relatives of EPI64.
Figure 2. cDNA sequence and genomic structure of the EPI64
gene. (A) Nucleotide and derived protein sequences of human
EPI64 cDNA. The TBC/rabGAP domain is underlined. Intron/
exon boundaries are indicated by arrowheads, and the COOH-
terminal PDZ–binding motif is boxed. These sequence data are
available from GenBank/EMBL/DDBJ under accession number
AF331038. (B) Schematic diagram of the intron and exon seg-
ments comprising the EPI64 gene. Boxes indicate exons and are
numbered sequentially from 59 to 39. 
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Several cDNA clones containing peptides identical to
those found in the 120-kD PDZ domain binding candidate
were also obtained from the human EST database. Com-
plete nucleotide sequencing of two clones from placental
and nasal epithelial libraries revealed them to be incom-
plete, but showed that the derived COOH-terminal pro-
tein sequences terminated with the amino acids STAL.
This COOH-terminal sequence is predicted to bind
EBP50 PDZ-1 and fits the more general consensus se-
quence X-(S/T)-X-(L/V/I) for a broad spectrum of PDZ
domain–binding proteins (Saras and Heldin, 1996; Song-
yang et al., 1997). This terminus is followed by the same 3
 
9
 
untranslated and poly A regions in these clones. There-
fore, it seems likely that the 120-kD placental protein
binds, like EPI64, via its COOH terminus to the PDZ do-
mains of EBP50.
BLAST searches of GenBank/EMBL/DDBJ with either
the nucleotide or deduced protein sequences from these
clones identified two protein sequences that had been en-
tered into the database during the course of this work.
One of these was a partial sequence of a hypothetical hu-
man protein (sequence data available from GenBank/
EMBL/DDBJ under accession number BAA91532), and
the other is a complete sequence coding for rat brain
nadrin, a 780–amino acid protein described as a novel neu-
ron-specific rho GTPase-activating protein involved in
Figure 3.  Alignment of
EPI64 with related protein
sequences. (A) EPI64 has a
TBC/rabGAP domain. TBC/
rabGAP domains of proteins
from diverse species were
aligned with EPI64 sequences
using the CLUSTAL algo-
rithm of the MEGALIGN
software program (DNAS-
TAR). The complete se-
quences of these proteins are
available at the following
GenBank/EMBL/DDBJ ac-
cession numbers: Homo sapi-
ens BAB14454 (BAB14454),
Halocynthia roretzi HrPET-1
(BAA81906),  Arabidopsis
thaliana PAM1 (AAC33763),
H. sapiens rab6 GAP
(NP_036329), Mus musculus
HBLP1 (NP_061245), Sac-
charomyces cerevisiae Pim1p
(AAB01977),  H. sapiens
VRP (NP_008994), H. sapi-
ens EVI5 (NP_005656),
Drosophila melanogaster RN-
tre (AAC48286), Bos taurus
Lyncein (CAA76943), M.
musculus Tbc1 (AAA85223),
D. melanogaster Pollux
(AAB02200), and H. sapiens
Tre-2 USP6 (NP_004496).
Residues matching the con-
sensus sequence are shaded.
A well-conserved arginine
residue, critical for yeast
Gyp1p and Gyp7p GAP ac-
tivity, is indicated (*). (B)
EPI64 demonstrates signifi-
cant homology to HrPET-1
and is closely related to the
unknown human protein
BAB14454. An alignment of
the full protein sequences
of EPI64, HrPET-1, and
BAB14454 is shown. The
TBC/rabGAP domain is
overlined. Sequence identities
matching the consensus are
shaded. 
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regulated exocytosis (Harada et al., 2000). The hypotheti-
cal human protein, which was isolated as a clone from a
neuronal precursor cell library (sequence data available
from GenBank/EMBL/DDBJ under accession number
BAB14454), is almost certainly a human isoform of rat
brain nadrin based on protein sequence alignments exhib-
iting very few, minor, and conservative residue differ-
ences. (The deposited nucleotide sequence appears to
have a four-base deletion after nucleotide 616; the down-
stream homology inferred here assumes a correction of
this presumed error.) Peptides derived from the 120-kD
placental protein align with rat brain nadrin throughout its
sequence (Fig. 4). However, the human EST clones de-
scribed above have regions of perfect alignment with rat
brain nadrin punctuated by at least two regions where the
sequence has no similarity: we interpret this as suggesting
that nadrin is alternatively spliced and that we have identi-
fied the human placental isoform. One of the peptides de-
rived from the 120-kD placental protein lies in the
rhoGAP domain of nadrin, indicating that the 120-kD pro-
tein has this domain.
 
Expression of Recombinant EPI64 and Mapping of the 
EBP50 Association Site to the Extreme COOH 
Terminus of EPI64
 
EPI64 was expressed as a recombinant protein in 
 
E
 
. 
 
coli
 
 to
better characterize it and its association with EBP50. Both
untagged and GST fusions of full-length EPI64 were gen-
erated. Fig. 5 A shows that, when untagged EPI64 is puri-
fied from bacterial extracts on EBP50 PDZ-1
 
1
 
 affinity
beads, it comigrates with the 64-kD species from human
placenta. These results suggest that the cDNA contains
the full-length coding sequence of EPI64. In addition, they
indicate that EPI64 migrates somewhat anomalously in
SDS-PAGE relative to its calculated molecular mass of
57.1 kD.
The presence of the COOH-terminal -DTYL sequence
in EPI64 suggests that it might bind to a PDZ domain of
EBP50 through this motif. To test this, GST–EPI64 fusion
proteins possessing either the wild-type COOH terminus,
-DTYL, or a mutated COOH terminus with an additional
alanine, -DTYLA, were generated. Based on previous
work (Hall et al., 1998a; Short et al., 1998; Cao et al.,
1999), we surmised that the addition of a single alanine
residue might be sufficient to disrupt the predicted PDZ–
COOH terminus interaction and chose to use a blot
overlay assay to assess this. The GST–EPI64–DTYL and
-DTYLA proteins were purified on glutathione–agarose
and eluted, and a sample of each was resolved by SDS-
PAGE. These proteins were then either stained in the gel
with Coomassie blue to evaluate their status after purifica-
tion (Fig. 5 B), or were transferred to a membrane and in-
cubated with biotin-labeled EBP50 probe (Fig. 5 C). Al-
though considerable degradation of the fusion proteins
occurred during these manipulations, the EBP50 probe
clearly bound to the construct containing the wild-type
COOH terminus but not to the construct in which the
COOH terminus was mutated, indicating that the associa-
tion of EPI64 with the PDZ domains of EBP50 requires its
extreme COOH terminus.
E3KARP is a human protein closely related to EBP50
that shares 
 
z
 
55% overall sequence identity, the predomi-
nance of which is found over the two PDZ domains (Rec-
zek et al., 1997; Yun et al., 1997). Like EBP50, E3KARP
has also been found to bind members of the ERM family,
Figure 4. The 120-kD human placental protein is an isoform of rat
brain nadrin. A schematic diagram showing the domain structure
of rat brain nadrin is shown with peptides derived from the se-
quencing of the human 120-kD protein mapped onto it. Peptides
are lettered a–g and have the following sequences: a, TEV-
LSEDLLQIER; b, MLETCGDAENQLALELSQHEVFVEK; c,
LVLDWDSVR; d, LAQTSDVNK; e, KPAPAPPK; f, NRPSVP-
PPPQPPGVHSAGDSSLTNTAPTASK; g, SIFPEMHSDSASK.
Figure 5. Expression of recombinant EPI64 and mapping of the
EBP50 and E3KARP association sites to the extreme COOH
terminus of EPI64. (A) Recombinant EPI64 comigates with the
64-kD species from placental microvilli. Recombinant EPI64 puri-
fied from bacterial extracts was resolved by SDS-PAGE adjacent to
a sample of EPI64 purified from placental microvilli. The proteins
were transferred to PVDF and then detected via an EBP50 PDZ
domain blot overlay. (B) Coomassie-stained gel of wild-type
(DTYL) and COOH-terminal mutant (DTYLA) GST–EPI64 af-
ter purification on glutathione–agarose. A fraction of the samples
from B were resolved by SDS-PAGE, transferred to PVDF mem-
brane, and probed with biotinyl EBP50 (C), or biotinyl E3KARP
(D). Arrows indicate the migration of the full-length GST–EPI64
fusion proteins. Additional signal for lower molecular mass bands
in D result from background seen in control blots.The Journal of Cell Biology, Volume 153, 2001 198
although it does not appear to bind merlin (Murthy et al.,
1998; Reczek and Bretscher, 1998; Yun et al., 1998;
Nguyen et al., 2001). Based on these similarities, we ex-
plored the possibility that EPI64 might also bind the PDZ
domains of E3KARP. A blot overlay assay using a biotin-
ylated E3KARP probe was performed on the same samples
described above. Like EBP50, E3KARP also bound tightly
to wild-type EPI64 but not to the mutant form, indicating
that it can also associate with EPI64, and it can do so in a
manner requiring the extreme COOH terminus (Fig. 5 D).
It is of interest to note that the numerous degradation
products of GST–EPI64 present after purification (Fig. 5
B) that contain the NH2 terminally fused GST moiety, as
confirmed by immunoblot analysis, are not recognized, as
they lack the EPI64 COOH-terminal sequences (Fig. 5, C
and D). This further substantiates that the interaction with
the PDZ domains is COOH terminally mediated.
Figure 6. Tissue and cell distribution of EPI64. 100 mg of total
proteins from murine tissues and human placenta and 2 and 10
mg of total proteins from isolated human placental microvilli (left),
or 400 mg of total proteins from the indicated cultured human cell
lines (right) were resolved by SDS-PAGE, transferred to PVDF
membrane, and probed with affinity-purified antibodies to EPI64.
The mobilities of molecular mass standards in kD are indicated at
left. DF, dye front.
Figure 7. Localization of
EPI64 in human placenta.
Cryosections of placenta
were stained with affinity-
purified antibodies to EPI64
(A), EBP50 (D), and ezrin
(G) and double-labeled for
actin using rhodamine phal-
loidin (B, E, and H). (C, F,
and I) Merged images. EPI64
colocalizes with actin in the
microvilli-rich region of the
syncytiotrophoblast (arrow-
heads) in a pattern that is
very similar to that seen for
EBP50 and ezrin. Bar, 40 mm.Reczek and Bretscher EPI64, a Microvillar PDZ Domain–binding Protein 199
Tissue and Cell Distribution and Localization of EPI64
Recombinant GST–EPI64 was used to elicit antibodies in
rabbits that were then affinity purified from the resulting
antiserum and used to examine the tissue and cell distri-
bution of endogenous EPI64. Immunoblots of normal-
ized total SDS-soluble lysates of murine and human tis-
sues indicated that EPI64 is present to some extent in
most of the tissues examined, with the exception of skele-
tal muscle (Fig. 6, left). It is most abundant in kidney and
is also found in lung, stomach, spleen, and placenta. As
such, it shows a striking correspondence with the distri-
bution of EBP50 in these tissues (compare with Figure 8
in Reczek et al., 1997). Database searches reveal that
cDNAs for EPI64 have been isolated from neurons, germ
cell tumors, infant brain, breast, prostate, and uterus.
Moreover, immunoblots show that EPI64 is significantly
enriched in microvillar proteins over total placental pro-
teins (Fig. 6, left). We conclude that EPI64 is widely dis-
tributed in tissues and is enriched in purified placental
microvilli.
Immunoblotting of total SDS-soluble lysates from dif-
ferent human cell cultures shows that EPI64 is seen to
varying extents in all the lines examined (Fig. 6, right),
similarly to EBP50 (data not shown). A doublet band at
z93–95 kD is also recognized by the antibodies in MRC-5
and HeLa cell lysates and may represent one or more po-
tential alternatively spliced EPI64 isoforms, or a closely
related protein(s). Interestingly, similar polypeptide bands
are seen in some of the lysates of murine tissues, particu-
larly those containing cells of muscle origin, and may be
indicative of a similar scenario (Fig. 6, left). The presence
of a major z70-kD immunoreactive form in brain (Fig. 6)
may also be a related protein, or result from alternative
splicing of the gene.
Figure 8. Localization of
EPI64 in JEG-3 cells. Hu-
man JEG-3 cells transiently
transfected with Xpress
epitope-tagged EPI64 were
fixed and double labeled to
detect Xpress-tagged EPI64
(A, D, and G), and EBP50
(B), or ezrin (E), or F-actin
(H). (C, F, and I) Merged
images. Bar, 10 mm.The Journal of Cell Biology, Volume 153, 2001 200
The information obtained from our protein sequence
analysis and phosphatase treatment of placental EPI64
(Fig. 1 D) indicated that it exists as both a 64-kD species
and a phosphorylated 65-kD species. Both of these are rec-
ognized by our antiserum; however, they could only be re-
solved upon shorter exposure of the immunoblot (data not
shown). The resolution of EPI64 in the other total lysate
samples was insufficient to detect such multiple species.
Using the same antibodies, the localization of EPI64 was
compared with that of EBP50 and ezrin in human pla-
centa. Freshly cut cryosections were double labeled for ei-
ther EPI64 and actin, EBP50 and actin, or ezrin and actin
(Fig. 7). EPI64 appeared to be enriched in the region of
the syncytiotrophoblast containing abundant actin-rich
microvilli. Diffuse and less intense staining for EPI64 was
also seen in some of the cell layers beneath this region
(Fig. 7 A). This staining pattern is very similar to that seen
for EBP50 and ezrin (Fig. 7, D and G).
The localization of EPI64 in cultured human cells using
the affinity-purified EPI64 antibodies was unreliable, as
they did not yield appreciable specific staining. This was
somewhat surprising as this reagent worked well for the
immunohistochemical staining of placenta. We suspect
that the poor signal is due to the low levels of EPI64 in
cultured cells (Fig. 6, right). Therefore, human JEG-3 cul-
tured cells were transiently transfected to express epitope-
tagged EPI64. In transfected cells, EPI64 specifically local-
izes to the numerous surface microvilli (Fig. 8, A, D, and
G). The presence of the epitope tag permitted double la-
beling to compare the distribution of EPI64 with EBP50,
ezrin, or actin. The staining in double-labeled cells re-
vealed that EPI64 colocalizes precisely with EBP50 in mi-
crovilli and shows significant overlapping staining with
ezrin and cortical F-actin in these structures (Fig 8, D–I).
Expression of EPI64 also appeared to enhance the level of
EBP50 in microvilli (Fig. 8 B).
Figure 9. Localization of the
EPI64 COOH-terminal mutant
in JEG-3 cells. Human JEG-3
cells transiently transfected with
Xpress epitope-tagged EPI64
COOH-terminal mutant were
fixed and double labeled to
detect Xpress-tagged mutant
EPI64 (A, D, and G), and
EBP50 (B), or ezrin (E), or
F-actin (H). Bar, 10 mm.Reczek and Bretscher EPI64, a Microvillar PDZ Domain–binding Protein 201
To determine if the localization of EPI64 was dependent
on its COOH-terminal -DTYL sequence that binds EBP50,
the localization of epitope-tagged EPI64 with the COOH-
terminal alanine mutation was examined after transient
transfection (Fig. 9). Introduction of this construct into
JEG-3 cells showed that the addition of a single alanine res-
idue to the COOH terminus was sufficient to perturb the lo-
calization to microvilli and resulted in a grainy and diffuse
staining pattern (Fig 9, A, D, and G). Furthermore, mutant
EPI64 did not colocalize with EBP50, ezrin, or cortical
F-actin (Fig. 9, C, F, and I). These in vivo results strongly
support the in vitro data demonstrating an association be-
tween EPI64 and EBP50 and suggests that this interaction is
needed for the microvillar localization of EPI64.
Isolation of Protein Complexes on the Isolated Domains 
of EBP50 and Ezrin
The data presented here, in conjunction with our previous
biochemical studies (Reczek et al., 1997; Reczek and
Bretscher, 1998), suggested that it should be possible to as-
semble complexes of ezrin, EBP50, and EPI64, as well as
other potentially relevant interacting proteins, from ex-
tracts of human placental microvilli. To test this hypothe-
sis, agarose beads with immobilized full-length EBP50
(FL), its two PDZ domains (P1 1 P2), its COOH-terminal
fragment containing the ERM binding site (C) (Fig. 1 A),
or the ezrin NH2-terminal domain (Ez-N) were generated.
Total detergent soluble extracts of microvillar proteins
were incubated with the beads, unbound proteins were re-
moved by washing, and retained polypeptides were eluted
and analyzed by SDS-PAGE. (Fig. 10). As before (Fig. 1),
it is important to subtract the polypeptides contributed by
the beads in buffer alone to identify polypeptides derived
from the microvillar extract. The picture that emerges
from the retained polypeptide profile is remarkably con-
sistent with the documented protein–protein interactions.
Thus, the NH2-terminal domain of ezrin (lane labeled
Ez-N) retained EBP50, EPI64 and p120 nadrin (both pre-
sumably through EBP50), and ezrin, as well as some other
polypeptides. The polypeptides retained by the COOH-
terminal domain of EBP50 (lane C), together with those
retained by the two PDZ domains of EBP50 (lane labled
P1 1 P2), recapitulate the sum of the polypeptides re-
tained on the ezrin NH2-terminal domain, except of course
for EBP50 itself. The polypeptides retained on full-length
EBP50 (lane FL) are the sum of the polypeptides retained
on the two halves of EBP50. The self-consistency of this
analysis provides considerable support for the protein–
protein interactions documented here and elsewhere.
A recent study has suggested that EBP50 can self-asso-
ciate through PDZ–PDZ domain interactions (Fouassier
et al., 2000). In this study, we found no indication of the
ability of the immobilized PDZ domains to retain intact
EBP50 (Figs. 1 B and 10; P1 1 P2); at present we do not
know the reason for this apparent discrepancy.
This analysis also allowed us to identify additional com-
ponents that bind to the PDZ domains of EBP50. These in-
clude z140-, z107-, z68-, and z35-kD polypeptides seen
in eluates in the FL, P1 1 P2 and Ez-N lanes. Scaling up this
binding assay, sufficient quantities of the 140- and 68-kD
bands were recovered for protein sequence analysis. This
revealed that the 140-kD band is the b3 isoform of phos-
pholipase-C (PLC-b3), and the 68-kD band is a novel 641–
amino acid protein described as an X-linked calpain-like
protease according to unpublished information submitted
to GenBank/EMBL/DDBJ (under accession number
CAA04051). Interestingly, both PLC-b3 and the putative
protease end in amino acid sequences predicted to bind
PDZ domains NTQL and LTEL, respectively. The specific
81-kD band seen in the FL, C, and Ez-N eluates is ezrin, as
determined by immunoblot analysis (data not shown). An
additional specifically bound polypeptide of z43 kD was
seen only in the COOH bead eluate, but has not yet been
identified. These data demonstrate that it is possible to re-
cover in vivo protein complexes (consisting of ezrin, EBP50,
EPI64, placental nadrin, PLC-b3, etc.) over the isolated
protein domains of some of their constituents. Whether all
of these represent interactions that occur in microvilli in
vivo will have to await future localization studies.
Discussion
In this paper, we extend our analysis of the molecular
structure of the ezrin-based cortical cytoskeleton. Previ-
ously, we had identified EBP50 as a microvillar protein
isolated from placental extracts that bound to the NH2-ter-
minal domain of ezrin (Reczek et al., 1997), and we subse-
quently demonstrated that EBP50 only binds to activated
ezrin in which its binding site is unmasked (Reczek and
Bretscher, 1998). Using a similar approach to find poten-
tially relevant microvillar proteins that bind EBP50, we
have identified several polypeptides that have COOH-ter-
Figure 10. Assembly of protein complexes on the isolated do-
mains of EBP50 and ezrin. Buffer or total detergent-soluble ex-
tracts of placental microvilli (MV) were mixed with either GST–
agarose beads, agarose beads with GST fused to full-length
EBP50 (FL), its two PDZ domains (P1 1 P2), or its COOH-ter-
minal half containing the ERM binding site (C), or agarose beads
with the ezrin NH2-terminal domain (Ez-N). The beads were
then washed, bound proteins eluted and resolved by SDS-PAGE,
and the resulting gel was silver stained as described in the legend
to Fig. 1 B. The mobilities of molecular mass standards are indi-
cated in kD. The migration of specifically bound polypeptides of
determined identity are indicated at right. DF, dye front.The Journal of Cell Biology, Volume 153, 2001 202
minal sequences characteristic of proteins that bind di-
rectly to the PDZ domains of EBP50.
We refer to one of these EBP50 PDZ–binding polypep-
tides as EPI64. Compared with the other candidates, it dem-
onstrated the most robust and reproducible association with
the PDZ domains of EBP50 and, like EBP50 and ezrin, it is
highly enriched in isolated placental microvilli. Our analysis
of in vitro and in vivo PDZ binding, cell and tissue distribu-
tion, and localization data all indicate that EPI64 is a physi-
ologically relevant binding partner of EBP50.
EPI64 interacts directly with the PDZ domains of
EBP50, and this interaction requires a canonical PDZ as-
sociation with the COOH terminus of EPI64 that ends in
DTYL. Since this sequence matches an optimal EBP50
PDZ-1 binding consensus (Hall et al., 1998a; Wang et al.,
1998), EPI64 is predicted to have preference for the first
PDZ domain in vivo. This prediction is further substanti-
ated by the finding that soluble PDZ-1 fusion protein is
much more effective than PDZ-2 at competing the binding
of full-length EBP50 probe to endogenous EPI64 in ligand
overlay assays (data not shown). Interestingly, however,
immobilized fusion proteins containing either PDZ-1 or
PDZ-2 were seen to retain EPI64 equally well by affinity
chromatography, indicating that in this assay there did not
seem to be an apparent preference. (Fig. 1, B and C). Yet,
neither PDZ domain on its own bound EPI64 as well as
the fusion proteins containing PDZ-1 followed by z40
flanking amino acids (P11, residues 1–138) or the two
PDZ domains in tandem (P1 1 P2, residues 1–248) (Fig. 1,
B and C). This suggests that additional EBP50 sequences
flanking PDZ-1 may serve to fully stabilize the association
with EPI64, either by allowing better stabilization or ac-
cessibility of the PDZ domain itself, or by making other
contacts with EPI64.
The ability of E3KARP to bind EPI64 in vitro (Fig. 5) is
likely to rely on a similar mode of association given the
high level of overall sequence identity, particularly within
the PDZ domains, that it shares with EBP50 (Yun et al.,
1997). Using the atomic structure for the third PDZ do-
main of the synaptic protein PSD-95 as a model (Doyle et
al., 1996), it is possible to identify and compare the critical
residues in the PDZ domains of EBP50 and E3KARP that
are predicted to make contacts with a bound peptide.
These residues in EBP50 (K19, Y24, F26, H27, L28, G30,
R40, H72, and I79 in PDZ-1 and K159; Y164, F166, N167,
L168, S170, R180, H212, and I129 in PDZ-2) are identical
or well conserved compared with those in E3KARP, sug-
gesting that the peptide binding preferences of the EBP50
and E3KARP PDZ domains are likely to be extremely
similar, if not identical. Thus, a careful study comparing
the respective distribution and localization of EBP50 and
E3KARP with those PDZ ligands that have the potential
to bind both proteins will be needed to establish their bio-
logical relevance.
EPI64 is a 508–amino acid protein with no predicted
transmembrane domains, signal sequences, or acylation
motifs, suggesting it is a cytoplasmic protein. The most sa-
lient feature of EPI64 is the presence of the z200–amino
acid TBC/rabGAP domain between residues 111 and
311. These domains are well conserved across species and
have been found in a wide range of different proteins
from plant adhesion molecules to mammalian oncogenes
(Zhang et al., 1996; Neuwald, 1997). The name TBC de-
rives from the name of the murine protein, Tbc1, in which
this domain was first identified based on its similarity to
sequences in the tre-2 oncogene, and the yeast regulators
of mitosis, BUB2 and cdc16 (Richardson and Zon, 1995).
The connection of this domain with rab GTPase activation
stems from subsequent in-depth sequence analyses and
alignments (Neuwald, 1997) and recent work demonstrat-
ing that it appears to contain the catalytic activities of the
yeast rabGAPs, Gyp1p, and Gyp7p (Albert et al., 1999).
The yeast study has far provided the best evidence that
these domains function as rabGAPs. In addition to map-
ping the catalytic activity to this region, Albert et al.
(1999) identified a critical arginine residue within this do-
main that is necessary for the full GAP activities. The re-
cent crystal structure of the TBC/rabGAP domain of
Gyp1p supports the idea that this residue functions as a
catalytic arginine finger analogous to that seen in ras- and
cdc42-GAPs (Rak et al., 2000). Although the overall se-
quence identity that Gyp1p and Gyp7p share with EPI64
is rather low (z10%), it is interesting to note that this
identity is clustered across motifs within the TBC/rabGAP
domain that are best conserved with other TBC/rabGAP–
containing proteins (Neuwald, 1997; Albert and Gallwitz,
1999). Furthermore, the critical arginine in these yeast
GAPs is conserved within the TBC/rabGAP domain of
EPI64 (Fig. 3 A).
The lack of obvious effects of expressing wild-type or
mutant EPI64 in cultured cells on cell morphology or the
localization of EBP50, ezrin, or cortical F-actin (Figs. 8
and 9) suggests that EPI64 has functions independent of
this linkage. With its distinct localization to microvilli, it
would be uniquely positioned to regulate rab-mediated
membrane fusion events, such as those occurring during
the regulatory endocytic or exocytic trafficking of vesicles
carrying the transmembrane ion channels or receptors to
which EBP50 has also been shown to bind. As a rabGAP,
EPI64 would be expected to enhance the intrinsic rate of
hydrolysis of GTP on the active rab on an incoming vesi-
cle, perhaps providing a signal that it has reached an ap-
propriate target site. With respect to the potential regula-
tion of EPI64 itself, it is interesting to note that EPI64 is
differentially phosphorylated, which does not seem to af-
fect its association with EBP50 (Figs. 1 and 10), but may
have a role in directly regulating GAP domain activity or
perhaps in modulating the associations EPI64 makes with
other ligands.
The assembly of microvillar protein complexes on the
different domains of ezrin and EBP50 revealed that EPI64
is a component of a multiprotein complex in these struc-
tures. In addition to EPI64 and human p120 nadrin, we
also identified the b3 isoform of PLC, and the novel puta-
tive calpain-like protease, CANPX, in eluates from the
EBP50 PDZ domain beads (Fig. 10). PLC-b3 and CANPX
both end in COOH-terminal sequences predicted to bind
the PDZ domains of EBP50; thus, it is very likely that they
are binding directly to EBP50 in these complexes like
EPI64 and nadrin. The evidence presented in Fig. 1 B sug-
gests that CANPX even appears to have a distinct prefer-
ence for PDZ-1. A recent study by Hwang et al. (2000)
demonstrating the binding of PLC-b3 to the second PDZ
domain of E3KARP indicates that the interaction of this
protein with the PDZ domains of EBP50 is direct. More-
over, Tang et al. (2000) have shown that the b1 and b2 iso-Reczek and Bretscher EPI64, a Microvillar PDZ Domain–binding Protein 203
forms of PLC can bind the first PDZ domain of EBP50.
Interestingly, the recovery of PLC-b3 in our affinity bead
eluates was not consistently robust (compare Figs. 1 B and
10) and may reflect a respectively lower affinity for the
EBP50 PDZ domains than the other ligands we identified.
The plethora of proteins that have been suggested to in-
teract with the PDZ domains of EBP50 and/or E3KARP
begs the critical question of whether all, or just some, might
be physiologically important. In Table I, the experimentally
determined optimal EBP50 PDZ–binding peptide consen-
sus sequences are compared with identified ligands and
their COOH-terminal sequences. Many of the identified
ligands fit the optimal binding sequences well, but this is a
biased set, as many were suggested based on their COOH-
terminal sequences alone. Aside from the proteins identi-
fied in this study, only the b2AR was identified as a poten-
tial ligand biochemically and without regard to sequence.
An independent criterion might be whether the identified
ligand is colocalized in cells and subcellular structures with
EBP50 and/or E3KARP. For example, in cultured cells,
EBP50 colocalizes very closely with ezrin (Reczek et al.,
1997), and EPI64 colocalizes precisely with EBP50. How-
ever, such an analysis has not yet been achieved for most of
the other candidates. Is it possible that many different pro-
teins interact with the PDZ domains of EBP50? Ezrin and
EBP50 are both major components of isolated placental
microvilli (Berryman et al., 1995; Reczek et al., 1997), yet
the candidates that bind the PDZ domains of EBP50 ap-
pear to be less abundant. This apparent difference in stoi-
chiometry would suggest that many different proteins can
bind EBP50 even in one structure, and the finding that
many different EBP50 binding candidates can be retained
with EBP50 from extracts of placental microvilli argues for
this heterogeneity. If this is indeed the case, it would offer
one explanation as to how the presence of EPI64 in such
complexes might influence the trafficking of other EBP50-
associated proteins such as the b2AR, CFTR, or NHE3. It
might also allow a protease like CANPX to locally remodel
the cytoskeleton to facilitate such events. It will therefore
be very important in the future to determine binding hier-
archies and how the binding of one protein to a PDZ do-
main might affect the binding of other proteins to that or
the adjacent PDZ domain in EBP50.
Heterogeneous scaffolding complexes are becoming a
common feature of eukaryotic cell organization, with the
best example being those of the PSD in the dendritic spines
of neurons (Sheng and Pak, 2000). In these complexes,
there is also precedence for an EBP50–EPI64-like interac-
tion where the PDZ domain–containing protein PSD-95 as-
sociates with the rasGAP, SynGAP (Chen et al., 1998; Kim
et al., 1998). Another particularly relevant nonneuronal
example is the association of the fourth PDZ domain of
the FERM domain–containing protein PTPL1 with the
rhoGAP, PARG1 (Saras et al., 1997). The functional sig-
nificance of each of these GAP proteins in their respective
cellular milieus has yet to be elucidated. Likewise, determi-
nation of the functional implications of the EPI64–EBP50
interaction in the context of the ezrin-based cytoskeleton
will be an important challenge for future studies.
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